XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ DEFICIT (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

 

Exercise price  $1.21 
Expected dividend yield   0%
Risk free interest rate   1.73%
Expected life in years   10 
Expected volatility   146%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

      

Weighted

Average

  

Weighted

Average

 
   Number   Exercise Price   Remaining Life 
Stock Options               
                
Outstanding December 31, 2021   5,520,861   $1.84    6.32 
Granted   50,000   $1.21    9.78 
Expired   (16,000)  $5.60    - 
Exercised   -   $-    - 
Outstanding March 31, 2022   5,554,861   $1.83    6.11 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of March 31, 2022, and changes during the three months ended March 31, 2022, is presented below:

 

Nonvested Options  Options  

Weighted-

Average
Exercise Price

 
Nonvested at December 31, 2021   810,333   $3.08 
Granted   50,000   $1.21 
Vested   (92,812)  $1.70 
Forfeited   -   $- 
Nonvested at March 31, 2022   767,521   $3.01 
SUMMARY OF WARRANT ISSUANCES

A summary of warrant issuances are as follows:

 

      

Weighted

Average

  

Weighted

Average

 
   Number   Exercise Price   Remaining Life 
Warrants               
                
Outstanding December 31, 2021   6,132,630   $3.38    3.15 
Granted   16,000    1.25    4.77 
Expired   -    -    - 
Exercised   -    -    - 
Outstanding March 31, 2022   6,148,630   $3.37    2.91